Sonoma Pharmaceuticals GAAP EPS of -$0.08 beats by $0.13, revenue of $3.14M misses by $0.62M

• Sonoma Pharmaceuticals press release (NASDAQ:SNOA): Q3 GAAP EPS of -$0.08 beats by $0.13.
• Revenue of $3.14M (+6.8% Y/Y) misses by $0.62M.
• Shares -2% AH.

More on Sonoma Pharmaceuticals

• Seeking Alpha’s Quant Rating on Sonoma Pharmaceuticals
• Historical earnings data for Sonoma Pharmaceuticals
• Financial information for Sonoma Pharmaceuticals